NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)

Recruiting

Trial locations(33 sites)

Germany

Research Site, Amberg

Research Site, Bad Nauheim

Research Site, Bautzen

Research Site, Berlin

Research Site, Bielefeld

Research Site, Borna

Research Site, Bottrop

Research Site, Brandenburg an der Havel

Research Site, Braunschweig

Research Site, Dessau

Research Site, Dresden

Research Site, Ebersberg

Research Site, Essen

Research Site, Goslar

Research Site, Gütersloh

Research Site, Heilbronn

Research Site, Krefeld

Research Site, Landshut

Research Site, Leipzig

Research Site, Limburg

Research Site, Lüneburg

Research Site, Mainz

Research Site, München

Research Site, Nuremberg

Research Site, Plauen

Research Site, Rotenburg (Wümme)

Research Site, Siegen

Research Site, Solingen

Research Site, Torgau

Research Site, Unna

Research Site, Weningerode

Research Site, Winnenden

Research Site, Worms